Rockwell Medical, Inc. (RMTI) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
RMTI Revenue Growth
Revenue Breakdown (FY 2025)
RMTI's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
RMTI Revenue Analysis (2014–2025)
As of May 8, 2026, Rockwell Medical, Inc. (RMTI) generated trailing twelve-month (TTM) revenue of $17.39 billion, reflecting explosive growth of +91557.0% year-over-year. The most recent quarter (Q1 2026) recorded $17.34 billion in revenue, up 94394.7% sequentially.
Looking at the longer-term picture, RMTI's 5-year compound annual growth rate (CAGR) stands at +2.2%, indicating moderate growth over time. The company achieved its highest annual revenue of $101.5 million in 2024.
Revenue diversification analysis shows RMTI's business is primarily driven by Concentrate Products (100%). With over half of revenue concentrated in Concentrate Products, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including NKTR (-43.9% YoY), LXRX (+123.1% YoY), and SUPN (+16.3% YoY), RMTI has outperformed the peer group in terms of revenue growth. Compare RMTI vs NKTR →
RMTI Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| RMTICurrent | $17.4B | +91557.0% | +2.2% | -6.8% | |
 NKTR | $55M | -43.9% | -18.4% | -236.8% | |
 LXRX | $50M | +123.1% | +15.7% | -98.2% | |
 SUPN | $719M | +16.3% | +6.7% | -5.1% | |
 HALO | $1.4B | +37.6% | +39.2% | 58.4% | |
 PRGO | $4.3B | -3.6% | +0.8% | 8.1% |
RMTI Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $69.3M | -31.8% | $11.7M | 16.9% | $-4,691,000 | -6.8% |
| 2024 | $101.5M | +21.4% | $17.5M | 17.2% | $608K | 0.6% |
| 2023 | $83.6M | +14.8% | $8.7M | 10.4% | $-6,670,000 | -8.0% |
| 2022 | $72.8M | +17.6% | $4.1M | 5.6% | $-16,780,000 | -23.0% |
| 2021 | $61.9M | -0.4% | $-2,420,000 | -3.9% | $-30,336,000 | -49.0% |
| 2020 | $62.2M | +1.5% | $2.7M | 4.4% | $-28,420,000 | -45.7% |
| 2019 | $61.3M | -3.3% | $2.8M | 4.6% | $-34,095,290 | -55.6% |
| 2018 | $63.4M | +10.6% | $-1,584,540 | -2.5% | $-32,439,161 | -51.2% |
| 2017 | $57.3M | +7.5% | $3.7M | 6.5% | $-25,922,918 | -45.2% |
| 2016 | $53.3M | -3.7% | $6.8M | 12.7% | $-20,208,729 | -37.9% |
See RMTI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RMTI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RMTI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRMTI — Frequently Asked Questions
Quick answers to the most common questions about buying RMTI stock.
Is RMTI's revenue growth accelerating or slowing?
RMTI revenue is accelerating at +91557.0% year-over-year, exceeding the 5-year CAGR of +2.2%. TTM revenue reached $17.4B. Growth momentum has increased versus prior periods.
What is RMTI's long-term revenue growth rate?
Rockwell Medical, Inc.'s 5-year revenue CAGR of +2.2% reflects the sustained expansion pattern. Current YoY growth of +91557.0% is above this long-term average.
How is RMTI's revenue distributed by segment?
RMTI reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.